Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co – authored, adding:
“Here’s the important data from the French cohort of our Santorini study.
The message is the same.
Countries using combination therapy do better than those using statin based monotherapy like the UK and France .
Time to shift the needle to combination therapies from FDC to reduce pill burden especially.”
Title: Lipid management in high cardiovascular risk patients in France: a comparison with rest of Europe patients from 1-year follow-up of Santorini
Authors: Jean Ferrières, Kausik K. Ray, Alberico L. Catapano, Radhouan Allouche, Christian Becker, Aurélie Bardet, Michel Farnier
Read the Full Article on Frontiers in Cardiovascular Medicine
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 15:53Gregory Lim: Nicotine Products and Cardiovascular Risk
-
Aug 21, 2026, 15:26Mariusz Kruk: Plaque-Directed Intervention for the Prevention of Myocardial Infarction
-
Aug 21, 2026, 15:17Leveraging Data to Drive Sustainable Care for Haemophilia and Haemoglobinopathies – NNHF
-
Aug 21, 2026, 15:04Sex Differences in Platelet Function in Type 2 Diabetes – Seminars in Thrombosis and Hemostasis
-
Aug 21, 2026, 15:04Parth Parmar: RBC Morphology – A Practical Guide to Blood Smear Interpretation
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis